NCT04618861 is a clinical trial in Covid19, sponsored by Kafkas University.

Who is sponsoring NCT04618861?

NCT04618861 is sponsored by Kafkas University.

What condition does NCT04618861 study?

NCT04618861 studies Covid19, Pneumonia, Surfactant Protein Deficiency.

Is NCT04618861 still recruiting?

NCT04618861 is currently completed. Last updated 6 November 2020.

Last reviewed 2020-11-06 · How we verify

NCT04618861

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study

Completed Last updated 6 November 2020

What this trial tests

trial in Covid19 in 127 participants. Completed in 2 November 2020.

Timeline

13 October 2020

Primary endpoint
2 November 2020

2 November 2020

Quick facts

Lead sponsor	Kafkas University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	127
Start date	13 October 2020
Primary completion	2 November 2020
Estimated completion	2 November 2020
Sites	1 location across Turkey (Türkiye)

Conditions studied

Covid19 — all drugs for Covid19 →
Pneumonia — all drugs for Pneumonia →
Surfactant Protein Deficiency — all drugs for Surfactant Protein Deficiency →

Sponsor

Kafkas University

Who can join

18 and older, any sex, with Covid19 or Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to provide some insight into the variation of SD-D protein levels in patients with Covid-19 (-) pneumonia, Covid-19 (+) pneumonia, and CT negative Covid-19 infection in comparison to the normal population through a larger number of cases. Objective of the study is to determine the serum surfactant protein D (SP-D) levels in Covid-19 pneumonia infection.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.
Wang S, Li Z, Wang X, Zhang S, et al · · 2021 · cited 36× · PMID 34267664 · DOI 10.3389/fphar.2021.698905
Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.
Krygier A, Szmajda-Krygier D, Świechowski R, Pietrzak J, et al · · 2022 · cited 12× · PMID 36551272 · DOI 10.3390/biom12121845

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Kafkas University trials

Trials by the same sponsor.

NCT07296757 — The Effect of Origami Activities on Comfort Level and Quality of Life · NA · enrolling by invitation
NCT06807047 — Effect of the EpiSchool-M App on Teachers' Epilepsy Knowledge, Attitudes, and Self-Management · NA · completed
NCT06645457 — The Effect of Stress Ball and 4-7-8 Breathing Technique on Fear, Anxiety and Physiological Parameters · NA · completed
NCT06675773 — The Effect of Conscious Awareness Development Psychoeducation Program Prepared for Caregivers · NA · not yet recruiting
NCT06749067 — Effect Of Awareness and Occupatıonal Practıces On Menopausal Women's Psychologıcal Wellbeıng And Menopausal Symptoms · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04618861 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafkas University
Last refreshed: 6 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing